Loading organizations...
Loading organizations...
Rad AI is a technology company.
Rad AI develops generative AI solutions specifically for healthcare, focusing on optimizing radiology workflows. The company's core offerings include AI-driven impressions, automated report generation, and patient follow-up management through products like Rad AI Reporting, Rad AI Impressions, and Rad AI Continuity. These platforms are designed to streamline operations, enhance diagnostic accuracy, and ultimately improve patient care by leveraging advanced artificial intelligence.
Rad AI was co-founded in 2018 by Jeff Chang, an emergency radiologist who previously held the distinction of being the youngest radiologist in the United States. Chang's extensive experience on the front lines of radiology, coupled with his keen interest in machine learning, provided the foundational insight for the company: to combat increasing patient volumes, workforce shortages, and pervasive provider burnout by empowering radiologists with intelligent, workflow-enhancing tools.
The company's generative AI platforms are utilized by a significant portion of US health systems and many of the largest radiology practices. Rad AI aims to save radiologists time, alleviate professional burnout, and elevate the overall standard of patient care. Its long-term vision centers on continuously innovating AI solutions that are crafted by radiologists, for radiologists, ensuring practical utility and clinical relevance.
Rad AI has raised $155.0M across 6 funding rounds.
Rad AI has raised $155.0M in total across 6 funding rounds.
Rad AI has raised $155.0M in total across 6 funding rounds.
Rad AI's investors include Andy Crowder, CHCIO, CDH-E, Doug Hayes, Christian Rische, Feby Abraham, Array Ventures, Stuart Peterson, Gradient Ventures, Kickstart Fund, Transformation Capital, Trucks Venture Capital, Conor Bronsdon, Hari Lakshmanan.
Rad AI is a radiologist-led technology company specializing in generative AI solutions for radiology, founded in 2018 to address healthcare challenges like rising patient volumes, radiologist shortages, and provider burnout.[1][2][3] Its flagship products—Rad AI Reporting, Rad AI Impressions, and Rad AI Continuity—streamline reporting, generate AI-driven impressions, and ensure patient follow-ups for issues like potential cancers, serving over 40% of US health systems, 9 of the 10 largest radiology practices, and impacting nearly 50 million patients annually.[1][3][5] The company has demonstrated explosive growth, ranking 19th on the 2024 Deloitte Technology Fast 500 with 8,710% revenue growth, securing a spot on the 2025 CNBC Disruptor 50, and raising $50 million in funding.[3][5][6]
Rad AI was founded in 2018 by the youngest radiologist in US history, with a team of radiologists building AI tools directly from clinical needs to tackle repetitive tasks in radiology workflows.[2][5][7] The idea emerged from firsthand experience with inefficiencies in radiology reporting and patient follow-up, leading to the creation of the first generative AI application in healthcare—Rad AI Impressions—which gained widespread adoption among thousands of US radiologists.[3][6] Early traction came from proprietary large language models (LLMs) trained on massive radiology datasets, enabling rapid scaling; by 2021, it was named "Best New Radiology Vendor" by AuntMinnie and featured in CB Insights' Digital Health 150.[2][5] Pivotal moments include exclusive partnerships with leading health systems and a focus on real-world impact, such as reducing report error rates by up to 47%.[5][6]
Rad AI rides the generative AI wave in healthcare, specifically targeting radiology amid surging imaging volumes (up due to aging populations), a radiologist shortage, and outdated infrastructure straining health systems.[1][3] Its timing is ideal as LLMs mature post-2023 AI boom, positioning it as the first mover with widespread adoption where others struggle; market forces like staffing crises and burnout (affecting providers) favor its efficiency gains, enabling faster turnarounds and better outcomes for 50 million patients yearly.[3][5][6] By influencing ecosystem standards—through co-development with top practices and reducing follow-up gaps—Rad AI accelerates AI integration in diagnostics, potentially saving lives via prompt cancer detection and setting benchmarks for clinician-centric AI.[5][7]
Rad AI's momentum—fueled by 8,710% growth, executive expansions, and dominance in radiology AI—positions it to expand beyond reporting into full care continuity, targeting even broader health system adoption amid AI regulatory tailwinds.[3][6] Trends like multimodal AI (integrating imaging with text) and value-based care will shape its path, amplifying efficiency as volumes rise 20-30% annually. Its influence may evolve from workflow optimizer to indispensable platform, potentially via acquisitions or IPO, solidifying radiologist empowerment as the core of healthcare innovation.[3][5][7]
Rad AI has raised $155.0M across 6 funding rounds. Most recently, it raised $8.0M Series C in May 2025.